Accueil Site » Retour liste annuaire » plateforme : Antiviral Drug Design Platform-AD2P

Antiviral Drug Design Platform-AD2P
Responsable : Jean-Claude Guillemot • Responsable Tech. : Barbara Selisko
Adresse : AFMB-Polytech
Campus de Luminy
13009 Marseille



Pas de certification ISO

Site web

Presentation de la plate-forme

Plateforme multisites (cf ci-dessous)

Moyens et equipements


• BSL-2 dedicated to radionucleotides handling experiments
• BSL-2 of cell culture
• 1 robot Beckman NX (96 wells plate head)
• 1 robot Beckman 3000 (1 and 8 tips) in BSL-2 radionucleotide environment
• WallacMicroBeta trilux (Perkin Elmer)
• Phospho-imager Fujifilm (Life science)
• PheraStar omega (BMG Labtech)
• fluorimètre Tecan Safire2
• Storage space for > 60 000 chemical molecules)
• LISM (Modul Bio)


Linux Centos Cluster:
• 32 CPU Intel Xeon running @3,00 Ghz
• 64Go Memory
• 4To-Raid 5-Fiber Chanel-SAS Storage (hard drive)
• 10 Gbytes internal ethernet network
State of the art molecular modeling software:
• Chemo-Informatic: Tripos package (Sybyl, molcad, biopolymer, UNITY, UNITY3D, QSAR, HQSAR, CoMFA, Topomer search, Topomer CoMFA, Volsurf plus, Selector…)
• Docking Protein-Ligand: FlexX (BiosolveIT), OpenEye, Autodock
• Docking Protein-Protein: Haddock, Chemera
• Molecular Dynamics Simulation: CHARMM, NAMD, VMD
• Molecular Visualization & Structure Calculations: pymol, modeller, CNS, ARIA


BSL-3 screening space, fully equipped with 2 robots.
Q-PCR and dedicated robot


Aucun visuels disponibles.